IP Library Granted Patent US 12,626,169
Granted Patent B2
US 12,626,169 · App. 18/211,153 · Granted May 12, 2026

Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data

Inventors: Niven Rajin Narain (Cambridge, MA); Viatcheslav R. Akmaev (Sudbury, MA); Vijetha Vemulapalli (Westborough, MA)
Assignee: BPGbio, Inc.
G06N7/01G16H50/50G16H50/70
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,626,169
App. No.
18/211,153
Granted
May 12, 2026
Kind
B2
Abstract

Systems, methods, and computer-readable medium are provided for healthcare analysis. Data corresponding to a plurality of patients is received. The data is parsed to generate normalized data for a plurality of variables, with normalized data generated for more than one variable for each patient. A causal relationship network model is generated relating the plurality of variables based on the generated normalized data using a Bayesian network algorithm. The causal relationship network model includes variables related to a plurality of medical conditions or medical drugs. In another aspect, a selection of a medical condition or drug is received. A sub-network is determined from a causal relationship network model. The sub-network includes one or more variables associated with the selected medical condition or drug. One or more predictors for the selected medical condition or drug are identified.

Claims (29)

1 . A computer-implemented method for generating a causal relationship network model based on patient data, the method comprising:

accessing or obtaining normalized data for a plurality of variables, the normalized data corresponding to a plurality of patients and including diagnostic information and/or treatment information for each patient, wherein, for each patient, the normalized data includes more than one variable; and

generating a causal relationship network model relating the plurality of variables based on the normalized data for the plurality of patients using a programmed computing system including storage holding network model building code and a plurality of processors configured to execute the network model building code, the generating including creating and evolving an ensemble of probabilistic networks based on the normalized data for the plurality of patients, the causal relationship network model including variables related to a plurality of medical conditions, and the ensemble of probabilistic networks created and evolved in parallel on the plurality of processors.

2 . The method of claim 1 , wherein the causal relationship network model includes relationships indicating one or more predictors for each of the plurality of medical conditions.

3 . The method of claim 1 , wherein the accessed or obtained normalized data is not pre-selected as being relevant to one or more of the plurality of medical conditions.

4 . The method of claim 1 , wherein the plurality of patients includes a first subset of patients each having data indicating a diagnosis of a medical condition in the patient, and includes a second subset of patients each having data that does not indicate a diagnosis of the medical condition in the patient.

5 . The method of claim 1 , further comprising:

receiving updated or additional data corresponding to one or more of the plurality of patients or corresponding to one or more additional patients; and

updating the causal relationship network model based on the updated or additional data.

6 . The method of claim 1 , wherein the causal relationship network model is generated based solely on the normalized data.

7 . The method of claim 1 , further comprising:

determining a sub-network from the causal relationship network model, one or more variables in the sub-network associated with a selected medical condition or with a selected drug; and

probing relationships in the sub-network to determine one or more predictors for the selected medical condition or for the selected drug.

8 . The method of claim 7 , wherein the one or more predictors for the selected medical condition indicate a medical condition co-occurring with the selected medical condition.

9 . The method of claim 7 , wherein the extent of the sub-network is determined based on the one or more variables associated with the selected medical condition or with the selected drug and the strength of the relationships between the one or more variables and other variables in the causal relationship network model.

10 . The method of claim 7 , wherein the sub-network includes the one or more variables associated with the selected medical condition or with the selected drug, a first set of additional variables each having a first degree relationship with the one or more variables, and a second set of additional variables each having second degree relationship with the one or more variables.

11 . The method of claim 7 , wherein at least one of the one or more predictors is newly identified as a predictor for the medical condition or is newly identified as a predictor relevant to the selected drug.

12 . The method of claim 7 , further comprising:

displaying the one or more predictors in a user interface, the displaying including a graphical representation of the one or more variables, the one or more predictors, and relationships among the one or more variables and the one or more predictors.

13 . The method of claim 7 , further comprising displaying a graphical representation of the sub-network in a user interface.

14 . The method of claim 7 , further comprising ranking the one or more predictors based on strength of relationships between the one or more variables and the one or more predictors.

15 . The method of claim 7 , wherein the one or more predictors relevant to the selected drug indicates a drug administered in conjunction with the selected drug.

16 . The method of claim 7 , wherein the one or more predictors indicate an adverse drug interaction between the selected drug and one or more other drugs.

17 . The method of claim 1 , wherein the causal relationship network model is generated based on between 50 variables and 1,000,000 variables.

18 . The method of claim 1 , wherein the normalized data includes information from patient electronic health records.

19 . The method of claim 1 , wherein generating the causal relationship network model relating the plurality of variables based on the normalized data for the plurality of patients comprises:

creating a list of network fragments, each network fragment including two or more variables connected by one or more relationships, and determining a probabilistic score associated with each network fragment based on the normalized data;

creating an ensemble of trial networks that is an ensemble of Bayesian networks, each trial network constructed from a different subset of the list of network fragments; and

globally optimizing the ensemble of trial networks by evolving each trial network through local transformations in parallel using the plurality of processors to produce a consensus causal relationship network model.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 9, 2026
From: BERG LLC
To: BPGBIO, INC.
Reel/Frame 074281/0509 →
SECURITY INTEREST Recorded Aug 29, 2025
From: BPGBIO INC.
To: BERG SURVIVOR’S TRUST; BERG, KARA ANN; THLIVERIS, ANDREW T.
Reel/Frame 072805/0303 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2025
From: NARAIN, NIVEN RAJIN; AKMAEV, VIATCHESLAV R.; VEMULAPALLI, VIJETHA
To: BERG LLC
Reel/Frame 072074/0937 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 8147825 WAS ADDED PREVIOUSLY RECORDED AT REEL: 70903 FRAME: 693. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Apr 30, 2025
From: BPGBIO INC.
To: PHOENIX GENESIS LLC
Reel/Frame 071285/0001 →
SECURITY INTEREST Recorded Apr 21, 2025
From: BPGBIO INC.
To: PHOENIX GENESIS LLC
Reel/Frame 070903/0693 →
Continuity (4)
Continuation 16592069 · Oct 3, 2019
Continuation 14851846 · Sep 11, 2015
Provisional Application 62049148 · Sep 11, 2014
Related Publication 20240169223A1 · May 23, 2024
References Cited (123)
US 7415359B2 · Hill et al. · 2008 [cited by applicant]
US 7512497B2 · Periwal · 2009 [cited by applicant]
US 8000949B2 · Nikolskaya et al. · 2011 [cited by applicant]
US 8510245B2 · Stojadinovic et al. · 2013 [cited by applicant]
US 8571803B2 · Hill et al. · 2013 [cited by applicant]
US 9886545B2 · Narain et al. · 2018 [cited by applicant]
US 10061887B2 · Vishnudas et al. · 2018 [cited by applicant]
US 10482385B2 · Narain et al. · 2019 [cited by applicant]
US 11456054B2 · Narain et al. · 2022 [cited by applicant]
US 11734593B2 · Narain et al. · 2023 [cited by applicant]
US 12437835B2 · Vishnudas et al. · 2025 [cited by applicant]
US 20030017445A1 · Berg et al. · 2003 [cited by applicant]
US 20060019888A1 · Zhou · 2006 [cited by applicant]
US 20070038385A1 · Nikolskaya et al. · 2007 [cited by applicant]
US 20070134734A1 · Endo et al. · 2007 [cited by applicant]
US 20080046290A1 · Compton et al. · 2008 [cited by applicant]
US 20080208784A1 · Hill et al. · 2008 [cited by applicant]
US 20080294403A1 · Zhu et al. · 2008 [cited by applicant]
US 20090144034A1 · Simma et al. · 2009 [cited by applicant]
US 20090183268A1 · Kingsmore · 2009 [cited by applicant]
US 20090307160A1 · Minh et al. · 2009 [cited by applicant]
US 20100125042A1 · Geschwind et al. · 2010 [cited by applicant]
US 20100316629A1 · Shaughnessy, Jr. et al. · 2010 [cited by applicant]
US 20110027291A1 · Schoeberl et al. · 2011 [cited by applicant]
US 20110059861A1 · Nolan et al. · 2011 [cited by applicant]
US 20110112380A1 · Robinson · 2011 [cited by applicant]
US 20110131027A1 · Solomon · 2011 [cited by applicant]
US 20110229483A1 · Griffioen et al. · 2011 [cited by applicant]
US 20110294693A1 · Hu · 2011 [cited by applicant]
US 20120015838A1 · Hu · 2012 [cited by applicant]
US 20120060216A1 · Chaudhri et al. · 2012 [cited by applicant]
US 20120070849A1 · Perez et al. · 2012 [cited by applicant]
US 20120258874A1 · Narain · 2012 [cited by examiner]
US 20130023574A1 · Araki et al. · 2013 [cited by applicant]
US 20130259847A1 · Vishnudas et al. · 2013 [cited by applicant]
US 20130275153A1 · Dastmalchi et al. · 2013 [cited by applicant]
US 20130315885A1 · Narain et al. · 2013 [cited by applicant]
US 20140227693A1 · Helgadottir et al. · 2014 [cited by applicant]
US 20150023949A1 · Narain et al. · 2015 [cited by applicant]
US 20180275146A1 · Narain et al. · 2018 [cited by applicant]
US 20190242909A1 · Narain et al. · 2019 [cited by applicant]
US 20220137070A1 · Narain et al. · 2022 [cited by applicant]
CN 1087187A · 1994 [cited by applicant]
CN 1714371A · 2005 [cited by applicant]
CN 101105841A · 2008 [cited by applicant]
CN 101151615A · 2008 [cited by applicant]
CN 103493054A · 2014 [cited by applicant]
CN 103501859A · 2014 [cited by applicant]
DE 102007044380A1 · 2009 [cited by applicant]
EP 0590305A2 · 1994 [cited by applicant]
EP 1840574A1 · 2007 [cited by applicant]
EP 1887351A1 · 2008 [cited by applicant]
EP 2600154A1 · 2013 [cited by applicant]
EP 2778130A1 · 2014 [cited by applicant]
EP 3191975A1 · 2017 [cited by applicant]
JP 20056563A · 2005 [cited by applicant]
JP 200865836A · 2008 [cited by applicant]
JP 2008510481A · 2008 [cited by applicant]
JP 2008528975A · 2008 [cited by applicant]
JP 200950171A · 2009 [cited by applicant]
JP 2010511404A · 2010 [cited by applicant]
JP 2011512163A · 2011 [cited by applicant]
JP 2012500036A · 2012 [cited by applicant]
JP 2013537326A · 2013 [cited by applicant]
JP 2014512520A · 2014 [cited by applicant]
JP 2015503185A · 2015 [cited by applicant]
WO 199729447A2 · 1997 [cited by applicant]
WO 2002072871A2 · 2002 [cited by applicant]
WO 2003023573A2 · 2003 [cited by applicant]
WO 2005024421A1 · 2005 [cited by applicant]
WO 2005106038A2 · 2005 [cited by applicant]
WO 2006021810A1 · 2006 [cited by applicant]
WO 2006054991A1 · 2006 [cited by applicant]
WO 2006079092A2 · 2006 [cited by applicant]
WO 2006103615A1 · 2006 [cited by applicant]
WO 2008060620A2 · 2008 [cited by applicant]
WO 2008068780A2 · 2008 [cited by applicant]
WO 2009020684A1 · 2009 [cited by applicant]
WO 2009085209A2 · 2009 [cited by applicant]
WO 2009105718A1 · 2009 [cited by applicant]
WO 2010018477A2 · 2010 [cited by applicant]
WO 2010056374A2 · 2010 [cited by applicant]
WO 2010132440A2 · 2010 [cited by applicant]
WO 2011112961A1 · 2011 [cited by applicant]
WO 2011125917A1 · 2011 [cited by applicant]
WO 2012051269A1 · 2012 [cited by applicant]
WO 2012119129A1 · 2012 [cited by applicant]
Ayala-Grosso et al., Caspase-3 cleaved spectrin colocalizes with neurofilament-immunoreactive neurons in Alzheimer's disease. Neuroscience. Aug. 25, 2006;141(2):863-874. [cited by applicant]
Bandyopadhyay et al., Rewiring of genetic networks in response to DNA damage. Science. Dec. 3, 2010;330(6009):1385-9. [cited by applicant]
Bignone et al., Phosphorylation of a threonine unique to the short C-terminal isoform of betall-spectrin links regulation of alpha-beta spectrin interaction to neuritogenesis. J Biol Chem. Jan. 12, 2007;282(2):888-96. [cited by applicant]
Choudhary et al., Decoding signalling networks by mass spectrometry-based proteomics. Nat Rev Mol Cell Biol. Jun. 2010;11(6):427-39. [cited by applicant]
Council on Competitiveness High Performance Computing, Bringing the power of HPC to Drug Discovery and the Delivery of “Smarter” Health Care. Case Study. Retrieved online at: http://www.compete.org/images/uploads/File/P… [cited by applicant]
Davidson et al., Is hyperglycemia a causal factor in cardiovascular disease? Does proving this relationship really matter? Yes. Diabetes Care. Nov. 2009;32 Suppl 2:S331-3. [cited by applicant]
De Jong, Modeling and simulation of genetic regulatory systems: a literature review. J Comput Biol. 2002;9(1):67-103. [cited by applicant]
El Samad et al., Stochastic modelling of gene regulatory networks. Intl J Robust Nonlinear Control. Sep. 2005;15:691-711. [cited by applicant]
Ferrara et al., Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling. PLoS Genet. Jul. 14, 2008;4(3):e1000034. 13 pages. [cited by applicant]
Gill et al., A statistical framework for differential network analysis from microarray data. BMC Bioinformatics. Feb. 19, 2010;11:95. [cited by applicant]
Gregg et al., Gene expression changes in children with autism. Genomics. Jan. 2008;91(1):22-9. [cited by applicant]
Grimaldi et al., RegnANN: Reverse Engineering Gene Networks using Artificial Neural Networks. PLoS One. Dec. 2011;6(12):e28646. 19 pages. [cited by applicant]
Hu et al., Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: evidence for circadian rhythm dysfunction in severe autism. Autism Res. Apr. 2009;2(2):78-97. [cited by applicant]
Hu et al., Gene expression profiling of lymphoblastoid cell lines from monozygotic twins discordant in severity of autism reveals differential regulation of neurologically relevant genes. BMC Genomics. 2006;7(1):118, 18… [cited by applicant]
Ideker et al., Differential network biology. Mol Syst Biol. Jan. 17, 2012; 8(565):1-9. [cited by applicant]
Imoto et al., Computational strategy for discovering druggable gene networks from genome-wide RNA expression profiles. Pac Symp Biocomput. 2006:559-71. [cited by applicant]
Jeromin et al., Age-related intraneuronal accumulation of II-spectrin breakdown product SBDP-120 in rodent forebrain accelerates in a transgenic model of Alzheimer's Disease: Novel link to neuroplasticity. Neuroscience … [cited by applicant]
Jorge et al., Statistical model to analyze quantitative proteomics data obtained by 18O/16O labeling and linear ion trap mass spectrometry: application to the study of vascular endothelial growth factor-induced angiogen… [cited by applicant]
Lee et al., An integrated approach to infer causal associations among gene expression, genotype variation, and disease. Genomics. Oct. 2009; 94(4):269-77. [cited by applicant]
Li et al., Large-scale dynamic gene regulatory network inference combining differential equation models with local dynamic Bayesian network analysis. Bioinformatics. Oct. 1, 2011;27(19):2686-91. [cited by applicant]
Liyan, Study on Data Mining Algorithm and Application. University of Electronic Science and Technology Press, 1st edition. p. 47, Feb. 2013. [cited by applicant]
PR Newswire, New Company, via Science, Created to Leverage REFS ‘Big Data’ Supercomputer Technology Across Multiple Industry Applications. Retrieved online at: http://www.prnewswire.com/news-releases/new-company-via-sci… [cited by applicant]
Qu et al., The Application of Bayesian Network Model in the Study of TCM Syndrome. Chinese Archives of Traditional Chinese Medicine. Jul. 2008;26(7):1947-1948. [cited by applicant]
Ratajczak, Theoretical aspects of autism: biomarkers—a review. J Immunotoxicol. Jan.-Mar. 2011;8(1):80-94. [cited by applicant]
Sachs et al., Causal protein-signaling networks derived from multiparameter single-cell data. Science. Apr. 22, 2005;308(5721):523-9. Erratum in: Science. Aug. 19, 2005;309(5738):1187. [cited by applicant]
Shannon et al., Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. Nov. 2003;13(11):2498-504. [cited by applicant]
Smoot et al., Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. Dec. 2010;27(3):431-2. [cited by applicant]
Tomshine et al., Optimization of a stochastically simulated gene network model via simulated annealing. Biophys J. Aug. 2006;91(9):3196-205. [cited by applicant]
Valcarcel et al., A differential network approach to exploring differences between biological states: an application to prediabetes. PLoS One. Sep. 2011;6(9):e24702. 9 pages. [cited by applicant]
Van Beijnum et al., Towards high-throughput functional target discovery in angiogenesis research. Trends Mol Med. Jan. 2006; 12(1):44-52. [cited by applicant]
Veenstra-Vanderweele et al., Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments. Neuropsychopharmacology. Jan. 2012;37(1):196-212. [cited by applicant]
Vujasinovic et al., In silico dynamic molecular interaction networks for the discovery of new therapeutic targets. Curr Pharm Des. 2010;16(20):2241-51. [cited by applicant]
Wu et al., Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol. Jan. 2007;292(… [cited by applicant]
Xing et al., Causal modeling using network ensemble simulations of genetic and gene expression data predicts genes involved in rheumatoid arthritis. PLoS Comput Biol. Mar. 2011;7(3):e1001105. [cited by applicant]
Zhang, Foundations of Computational Intelligence. Harbin Engineering University Press. p. 147, Mar. 31, 2001. [cited by applicant]
Chinese Office Action for Application No. 201580058049.5, dated Mar. 1, 2021, with English translation, 61 pages. [cited by applicant]